Ashland Inc.
ASHBasic MaterialsNASDAQSpecialty Chemicals · Last scanned Jul 18, 2026
Scan Results
Daily timeframeAshland Inc. provides additives and specialty ingredients in the North and Latin America, Europe, Asia Pacific, and internationally. At a $3.14B market cap, Ashland Inc. ranks as a mid-cap company within basic materials. It operates through Life Sciences, Personal Care, Specialty Additives, and Intermediates segments.
Market Cap
$3.14B
Beta
0.41
P/E (TTM)
—
P/E (Fwd)
16.12
EPS (TTM)
$-14.77
EPS (Fwd)
$4.26
ROE
-31.0%
ROA
2.0%
Cash
$343.0M
Total Debt
$1.48B
Free CF
$207.8M
52W Change
34.5%
Annual Financials
Cash vs Debt
On the balance sheet, ASH has $343.0M in cash with $1.48B in obligations. The ability to service this debt comfortably depends on continued operational cash generation. The company generates $207.8M in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. Return on equity stands at -31.0%, which is negative for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. ROA of 2.0% is on the lower side, which is common in asset-heavy industries. Revenue has pulled back from $2.39B (2022) to $1.82B (2025), a 24% decline worth watching.
ASH's low beta indicates it tends to be less volatile than the broader market, which may suit investors seeking more stable price behavior. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence Ashland Inc.'s trajectory.